What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Neuroscience
- Endocrinology
Priyattam J. Shiromani mostly deals with Internal medicine, Endocrinology, Neuroscience, Sleep in non-human animals and Rapid eye movement sleep.
His Internal medicine study often links to related topics such as Wakefulness.
His studies deal with areas such as Muscarinic acetylcholine receptor M4 and Muscarinic acetylcholine receptor M1 as well as Endocrinology.
In general Neuroscience study, his work on Cholinergic neuron, Locus coeruleus and Sleep induction often relates to the realm of Dorsal raphe nucleus, thereby connecting several areas of interest.
His research in Sleep in non-human animals is mostly concerned with Neuroscience of sleep.
His Lateral hypothalamus research includes themes of Orexin receptor, Orexin and Narcolepsy.
His most cited work include:
- Activation of Ventrolateral Preoptic Neurons During Sleep (862 citations)
- Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. (468 citations)
- Contrasting Effects of Ibotenate Lesions of the Paraventricular Nucleus and Subparaventricular Zone on Sleep–Wake Cycle and Temperature Regulation (269 citations)
What are the main themes of his work throughout his whole career to date?
Priyattam J. Shiromani mainly focuses on Internal medicine, Endocrinology, Neuroscience, Sleep in non-human animals and Rapid eye movement sleep.
His research ties Wakefulness and Internal medicine together.
His research integrates issues of Neuroscience of sleep and Sleep onset in his study of Endocrinology.
His Sleep in non-human animals study incorporates themes from Melanin-concentrating hormone, Eye movement and Electroencephalography.
His research investigates the link between Rapid eye movement sleep and topics such as Muscarinic acetylcholine receptor M1 that cross with problems in Biperiden.
His Circadian rhythm research is multidisciplinary, incorporating elements of Period and Core.
He most often published in these fields:
- Internal medicine (73.79%)
- Endocrinology (73.79%)
- Neuroscience (64.08%)
What were the highlights of his more recent work (between 2016-2021)?
- Neuroscience (64.08%)
- Sleep in non-human animals (52.43%)
- Amygdala (17.48%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Neuroscience, Sleep in non-human animals, Amygdala, Hypothalamus and Cataplexy.
He has included themes like Neuropeptide, Internal medicine and Lateral hypothalamus in his Sleep in non-human animals study.
His Hypothalamus study is concerned with the larger field of Endocrinology.
While working on this project, he studies both Endocrinology and Alcohol dependence.
His work carried out in the field of Cataplexy brings together such families of science as Muscle tone, Nucleus and Basolateral amygdala.
His Narcolepsy research is multidisciplinary, relying on both Orexin, Sleep disorder, Chemogenetics, Optogenetics and GABAergic.
Between 2016 and 2021, his most popular works were:
- Dynamic Network Activation of Hypothalamic MCH Neurons in REM Sleep and Exploratory Behavior. (23 citations)
- Dynamic Network Activation of Hypothalamic MCH Neurons in REM Sleep and Exploratory Behavior. (23 citations)
- VGAT and VGLUT2 expression in MCH and orexin neurons in double transgenic reporter mice. (8 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Neurology
- Psychiatry
Priyattam J. Shiromani spends much of his time researching Neuropeptide, Rapid eye movement sleep, Cell biology, GABAergic and Reporter gene.
The study of Neuroscience, Eye movement and Sleep in non-human animals are components of his Rapid eye movement sleep research.
His Cell biology research includes elements of Glutamate receptor, Glutamatergic and Orexin.
Melanin-concentrating hormone is closely attributed to Hypothalamus in his work.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
